Tom Ferkol, MD, is professor of pediatrics, cell biology, and physiology; director of the Division of Pediatric Allergy, Immunology, and Pulmonary Medicine at Washington University School of Medicine; and past president of the ATS. In addition, he serves as the director of the Pediatric Pulmonology Fellowship Training Program at Washington University School of Medicine and St. Louis Children's Hospital, and is past director of the comprehensive, accredited Washington University Cystic Fibrosis Center, which supports premier clinical and research programs in cystic fibrosis. The center is a member of the Cystic Fibrosis Foundation Therapeutics Development Network.
An American Lung Association Edward Livingston Trudeau Scholar and recipient of the Cystic Fibrosis Foundation LeRoy Matthew's Physician-Scientist Award, Dr. Ferkol has focused his research on developing of cell and animal models to study cystic fibrosis, defining genetic and molecular factors that contribute to chronic endobronchial infection, inflammation, and airway injury. With funding from the National Institutes of Health, March of Dimes, and Cystic Fibrosis Foundation, he and his collaborators have developed novel approaches for airway-specific drug delivery and non-invasive measures of inflammation in the cystic fibrosis lung.
